Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 64 Guangzhou 47 Chengdu 45 Changsha 37 Chongqing 29
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University463 Ruijin Hospital284 Shanghai Zhongshan Hospital170 RenJi Hospital133 Children's Hospital of Fudan University84 Shanghai Chest Hospital80 Changhai Hospital80 Shanghai Jiao Tong University School of Medicine79 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine66 Shanghai Mental Health Center65 Huashan Hospital63 Shanghai Pulmonary Hospital, Shanghai, China55 Sichuan Baili Pharmaceutical Co., Ltd.51 Shanghai Changzheng Hospital50 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University49 Eye & ENT Hospital of Fudan University48 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine46 Hoffmann-La Roche37 Jiangsu HengRui Medicine Co., Ltd.37 AstraZeneca36 Shanghai 6th People's Hospital31 Novartis Pharmaceuticals29 Shanghai 10th People's Hospital29 Shanghai Eye Disease Prevention and Treatment Center28 Pfizer28 Shanghai East Hospital26 Eli Lilly and Company25 Akeso24 Sanofi23 Janssen Research & Development, LLC21 Suzhou Suncadia Biopharmaceuticals Co., Ltd.20 Merck Sharp & Dohme LLC20 Boehringer Ingelheim16 AbbVie16 GlaxoSmithKline15 Second Affiliated Hospital, Zhejiang University, School of Medicine14 Innovent Biologics (Suzhou) Co. Ltd.14 Bristol-Myers Squibb13 Takeda13 Qilu Pharmaceutical Co., Ltd.13 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.13 Changchun GeneScience Pharmaceutical Co., Ltd.13 Obstetrics & Gynecology Hospital of Fudan University12 ChinaNorm12 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.12 Shanghai Jiao Tong University Affiliated Sixth People's Hospital12 Mabwell (Shanghai) Bioscience Co., Ltd.11 BeOne Medicines11 Minghui Pharmaceutical (Hangzhou) Ltd11 Shanghai Juncell Therapeutics11 Shanghai Henlius Biotech11 Shanghai Children's Medical Center10 Amgen10 Shanghai Junshi Bioscience Co., Ltd.9 Shanghai Gynecologic Oncology Group9 Abbisko Therapeutics Co, Ltd9 Alexion Pharmaceuticals, Inc.9 Shanghai University of Traditional Chinese Medicine9 Shanghai University of Sport8 Tongji University8 Sun Yat-sen University8 Guangdong Hengrui Pharmaceutical Co., Ltd8 Haisco Pharmaceutical Group Co., Ltd.8 Wenjin Yin8 Grit Biotechnology8 Jiangsu Simcere Pharmaceutical Co., Ltd.8 Beijing GoBroad Hospital8 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.8 Shanghai Cell Therapy Group Co.,Ltd8 Children's Cancer Group, China7 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.7 Hansoh BioMedical R&D Company7 Jiangsu Hansoh Pharmaceutical Co., Ltd.7 First Affiliated Hospital of Zhejiang University7 Jin Yang7 Eastern Hepatobiliary Surgery Hospital7 Shenyang Sunshine Pharmaceutical Co., LTD.7 Shanghai General Hospital, China6 Shanghai Hengrui Pharmaceutical Co., Ltd.6 Shanghai Proton and Heavy Ion Center6 MediLink Therapeutics (Suzhou) Co., Ltd.6 RemeGen Co., Ltd.6 Peking Union Medical College Hospital6 Ascentage Pharma Group Inc.6 Xiamen Amoytop Biotech Co., Ltd.5 Xu Liu5 Shanghai Tong Ren Hospital5 Shanghai Vitalgen BioPharma Co., Ltd.5 Xiaojun Chen5 Astellas Pharma Global Development, Inc.5 Jiangsu Alphamab Biopharmaceuticals Co., Ltd5 LaNova Medicines Limited5 CSPC Megalith Biopharmaceutical Co.,Ltd.5 Jian Chen5 Shanghai Institute of Acupuncture, Moxibustion and Meridian5 Shanghai Tongji Hospital, Tongji University School of Medicine5 Rong Tao5 Beijing Tiantan Hospital5 Suzhou Zelgen Biopharmaceuticals Co.,Ltd5 Daiichi Sankyo5 Shanghai JMT-Bio Inc.5 Innostellar Biotherapeutics Co.,Ltd5 Fujian Shengdi Pharmaceutical Co., Ltd.5 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.5 argenx4 Actelion4 Dizal Pharmaceuticals4 Luye Pharma Group Ltd.4 Avistone Biotechnology Co., Ltd.4 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.4 ShangHai Ji Ai Genetics & IVF Institute4 Shanghai Huaota Biopharmaceutical Co., Ltd.4 Hutchmed4 International Peace Maternity and Child Health Hospital4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.4 Nanjing Medical University4 Beijing Friendship Hospital4 Genzyme, a Sanofi Company4 BioNTech SE4 Jiangsu Aosaikang Pharmaceutical Co., Ltd.4 Shanghai Minimally Invasive Surgery Center4 Celgene4 Shanghai Municipal Hospital of Traditional Chinese Medicine4 Weill Medical College of Cornell University4 Hrain Biotechnology Co., Ltd.4 Shanghai Public Health Clinical Center4 Shandong Suncadia Medicine Co., Ltd.4 Shenzhen Salubris Pharmaceuticals Co., Ltd.4 Shanghai Yueyang Integrated Medicine Hospital4 HC Biopharma Inc.3 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.3 Nanjing Sanhome Pharmaceutical, Co., Ltd.3 L & L Bio Co., Ltd., Ningbo, China3 Shanghai AbelZeta Ltd.3 Wayshine Biopharm, Inc.3 Tianjin ConjuStar Biologics Co., Ltd.3 BioRay Pharmaceutical Co., Ltd.3 Betta Pharmaceuticals Co., Ltd.3 Peking University3 Lepu Biopharma Co., Ltd.3 China National Center for Cardiovascular Diseases3 Juventas Cell Therapy Ltd.3 Nuvation Bio Inc.3 Peking University Third Hospital3 Guangzhou Medical University3 The University of Texas Health Science Center, Houston3 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School3 Sheng Zhang3 Ranok Therapeutics (Hangzhou) Co., Ltd.3 Zai Lab (Shanghai) Co., Ltd.3 Peking University First Hospital3 Genmab3 Ming Zhong3 Shanghai High Myopia Study Group3 Shanghai Synvida Biotechnology Co.,Ltd.3 Cascade Pharmaceuticals, Inc3 Yin Ping3 Chinese University of Hong Kong3 TYK Medicines, Inc3 Shanghai Best-Link Bioscience, LLC3 Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University3 Suzhou Genhouse Bio Co., Ltd.3 Beijing Anzhen Hospital3 Yan Li3 Boston Scientific Corporation3 Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.3 Baohui Han3 HuidaGene Therapeutics Co., Ltd.3 Yunfeng Cheng3 Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd3 Shanghai StairMed Technology Co., Ltd.3 Chipscreen Biosciences, Ltd.3 Nanjing Immunophage Biotech Co., Ltd3 UCB Biopharma SRL3 Bioray Laboratories3 InSilico Medicine Hong Kong Limited3 Zhigang Li3 VelaVigo Bio Inc3 Zhijun Bao3 Shanghai Cancer Hospital, China3 Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd3 Shanghai MicroPort CardioFlow Medtech Co., Ltd.3 ImmuneOnco Biopharmaceuticals (Shanghai) Inc.3 Evidence Based Cataract Study Group3 Shanghai Geriatric Medical Center3 Evopoint Biosciences Inc.3 Shanghai NewMed Medical Co., Ltd.3 Innovent Biologics Technology Limited (Shanghai R&D Center)3 Shanghai Pudong Hospital3 Shanghai Institute Of Biological Products2 Ausper Biopharma Co., Ltd.2 LEO Pharma2 Huijie Zhang2 Ipsen2 Zhejiang Doer Biologics Co., Ltd.2 Drug Induced Liver Disease Study Group2 Amway (China) R&D Center2 UCARsgen Biotech Limited2 Taizhou Mabtech Pharmaceutical Co.,Ltd2 Phrontline Biopharma2 BrosMed Medical Co., Ltd2 Laekna Limited2 Suzhou Huhu Health & Technology Inc.2 Atom Therapeutics Co., Ltd2 Hinova Pharmaceuticals Inc.2 Axter Therapeutics (Beijing) Co., Ltd2 Shanghai Pharmaceuticals Holding Co., Ltd2 Regend Therapeutics2 Shandong New Time Pharmaceutical Co., LTD2 Genfleet Therapeutics (Shanghai) Inc.2 Shouyao Holdings (Beijing) Co. LTD2 Shanghai IxCell Biotechnology Co., LTD2 Singlera Genomics Inc.2 Chongqing Peg-Bio Biopharm Co., Ltd.2 Gracell Biotechnologies (Shanghai) Co., Ltd.2 Ji Dongmei2 Jing Xu2 Jacobio Pharmaceuticals Co., Ltd.2 Jiayuan Sun2 Beijing InnoCare Pharma Tech Co., Ltd.2 Nanjing Bioheng Biotech Co., Ltd.2 Innolake Biopharm2 Shanghai Ming Ju Biotechnology Co., Ltd.2 ZhanYJ2 The First Affiliated Hospital with Nanjing Medical University2 Shanghai BDgene Co., Ltd.2 Eikon Therapeutics2 Zenas BioPharma (USA), LLC2 Genentech, Inc.2 LaNova Medicines Zhejiang Co., Ltd.2 Biogen2 Shanghai Bao Pharmaceuticals Co., Ltd.2 Tongji Hospital2 Sijia Gu2 Forward Pharmaceuticals Co., Ltd.2 CARsgen Therapeutics Co., Ltd.2 Geneplus-Beijing Co. Ltd.2 Shanghai Minhang Central Hospital2 Lifetech Scientific (Shenzhen) Co., Ltd.2 InxMed (Shanghai) Co., Ltd.2 Medtronic Cardiac Ablation Solutions2 OriCell Therapeutics Co., Ltd.2 ShuGuang Hospital2 Institut de Recherches Internationales Servier2 Yun Qian2 Guangzhou Jiayin Biotech Ltd2 Biosense Webster, Inc.2 Chinese Academy of Sciences2 Beijing Suncadia Pharmaceuticals Co., Ltd2 Nanjing IASO Biotechnology Co., Ltd.2 Tasly Pharmaceutical Group Co., Ltd2 GrandPharma (China) Co., Ltd.2 Bayer2 First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University2 Eisai Inc.2 Sunshine Lake Pharma Co., Ltd.2 Shanghai First Maternity and Infant Hospital2 Anhui Provincial Hospital2 Zhejiang Haichang Biotech Co., Ltd.2 magAssist, Inc.2 Imbioray (Hangzhou) Biomedicine Co., Ltd.2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2 MicroPort NeuroTech Co., Ltd.2 Shanghai Institute of Hypertension2 Therorna2 Jing-yuan Fang, MD, Ph. D2 Peng Zhang2 Shenzhen Fosun Kairos Biotechnology Co., Ltd.2 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 Suzhou Alphamab Co., Ltd.2 InventisBio Co., Ltd2 Incyte Corporation2 Servier Bio-Innovation LLC2 Ai Peng2 Zhen Wang2 Biotheus Inc.2 Chengdu New Radiomedicine Technology Co. LTD.2 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.2 Hongmeng Yu2 Acepodia Biotech, Inc.2 Yingbin Liu, MD, PhD, FACS2 Zhongguang Luo, MD2 Keda Yu2 Longbio Pharma2 Xijing Hospital2 Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology2 Shanghai Jiaolian Drug Research and Development Co., Ltd2 Shanghai UniXell Biotechnology Co., Ltd2 FutureGen Biopharmaceutical (Beijing) Co., Ltd2 Medtronic Cardiac Rhythm and Heart Failure2 Société des Produits Nestlé (SPN)2 Xuanzhu Biopharmaceutical Co., Ltd.2 Seagen, a wholly owned subsidiary of Pfizer2 Chengdu Zenitar Biomedical Technology Co., Ltd2 Tang-Du Hospital2 Zhejiang University2 International Extranodal Lymphoma Study Group (IELSG)2 D3 Bio (Wuxi) Co., Ltd2 Peking University People's Hospital2 Pierre Fabre Medicament2 CooperVision International Limited (CVIL)2 Shanghai Fourth People's Hospital Tongji University2 Bin Cao2 Candid Therapeutics2 Yilai Shu2 Chongqing Precision Biotech Co., Ltd2 Shanghai 7th People's Hospital2 The University of Hong Kong2 nthalmic Pty Ltd2 Energenx Medical LTD.2 Nanjing Leads Biolabs Co.,Ltd2 First Affiliated Hospital of Ningbo University2 Beijing Kanghong Biological Medicine Co., Ltd.2 Xiaonan Huang2 Keymed Biosciences Co.Ltd2 Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.2 The Hong Kong Polytechnic University2 Beijing Continent Pharmaceutical Co, Ltd.2 SightGlass Vision, Inc.2 Biokin (Shanghai) Biopharmaceutical Co., Ltd.2 Aibin Liang，MD，Ph.D.2 China-Japan Friendship Hospital2 Adcentrx Therapeutics1 Ensem Therapeutics1 Yinzhong Shen1 Otsuka Pharmaceutical Development & Commercialization, Inc.1 Cytokinetics1 Yang Fan, MD1 Zhiguo Luo, MD, PhD1 Frontera Therapeutics1 Sichuan University1 GenEditBio Limited1 CryoLife, Inc.1 Hangzhou Broncus Medical Co., Ltd.1 Bausch & Lomb Incorporated1 Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.1 Ruijin Hospital Luwan Branch1 NeuroXess Technology (shanghai) Co.,Ltd.1 H. Lundbeck A/S1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.1 Unidade Local de Saúde São João, Oporto1 The Fourth Affiliated Hospital of Soochow University1 SPH-BIOCAD (HK) Limited1 Guo Xufeng1 Inmunotek S.L.1 ADC Therapeutics S.A.1 Livzon Pharmaceutical Group Inc.1 Guangdong Ruishun Biotech Co., Ltd1 Intuitive Surgical1 Yan Xing1 Gao Xiaofeng1 Yufen Wu, MD1 DK Medical Technology (Suzhou) Co., Ltd.1 Vifor Fresenius Medical Care Renal Pharma1 Suzhou HepaThera Biotech Co., Ltd.1 HRYZ Biotech Co.1 Nanfang Hospital, Southern Medical University1 GeneCradle Inc1 Xynomic Pharmaceuticals, Inc.1 Linno Pharmaceuticals, Inc.1 EndoCell Therapeutics, Inc.1 Zhuhai Beihai Biotech Co., Ltd1 Hangzhou PhecdaMed Co., Ltd.1 Advenchen Laboratories, LLC1 Applied Pharmaceutical Science, Inc.1 Suzhou Biomissile Pharmaceuticals Co., Ltd.1 Chunshui He1 Womed1 Xiangyun Zong1 Monash University1 Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.1 Hope Medicine (Nanjing) Co., Ltd1 Shanghai Euhearing Therapeutics Co., Ltd1 IBSA Farmaceutici Italia Srl1 Yufan Wang1 Aligos Therapeutics1 Suzhou Abogen Biosciences Co., Ltd.1 Philips Clinical & Medical Affairs Global1 Angitia Biopharmaceuticals Guangzhou Limited1 Shanghai Dynaheart Medtech Co., Ltd.1 Jiannan Huang1 3H (Suzhou) Pharmaceuticals Co., Ltd.1 Junjie Xu1 Capital University of Physical Education and Sports, China1 Kun Sun1 Genuine Seed Therapeutics (Zhuhai) Co., Ltd.1 Zhangjie Yu1 Etern Therapeutics Wuxi Limited1 Lin Kong, MD1 Shanghai AB PharmaTech Ltd.1 Integra LifeSciences Corporation1 Haihe Biopharma Co., Ltd.1 AskGene Pharma, Inc.1 Astellas Pharma Inc1 Ma Yanlei1 Shanghai Simnova Biotechnology Co.,Ltd.1 Xiujuan Zang1 Longhua Hospital1 Gilead Sciences1 Beijing Jishuitan Hospital1 Tan Lijie1 The First Affiliated Hospital of Dalian Medical University1 Lai-ping Zhong1 Zhen Zhang1 Qing XIe1 Zhaoshen Li1 Kangabio AUSTRALIA LTD PTY1 Peking University International Hospital1 Sichuan Enray Pharmaceutical Sciences Company1 KK Women's and Children's Hospital1 BAIYONG SHEN1 FrontAce Scientific Co., Ltd1 Yan Hongli1 Suzhou Immunofoco Biotechnology Co., Ltd1 Jia Fan1 Edwards Lifesciences1 Virogin Biotech Ltd.1 Mao Jianhua1 Shuangyue Liu1 YiHui Guan1 Spectrumedics Medical Technology(Shanghai)Co.,Ltd1 Tianjin Medical University Second Hospital1 Epygenix1 Shenzhen Shenxin Biotechnology Co., Ltd1 CANbridge Life Sciences Ltd.1 Broadenbio Ltd., Co.1 Lei Lei, MD1 Suzhou UgeneX Therapeutics Co., Ltd.1 Sinocare1 NGGT (Suzhou) Biotechnology Co., Ltd.1 MedImmune LLC1 Tsinghua University1 Shen Lei1 Henan Genuine Biotech Co., Ltd.1 Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1 Wenzhou Medical University1 InSightec1 Jin LI1 Lu Wang, MD, PhD1 Xin Cai1 Shanghai Argo Biopharmaceutical Co., Ltd.1 DualityBio Inc.1 Jenscare Scientific1 The Dental Hospital of Zhejiang University School of Medicine1 Dragonboat Biopharmaceutical Company Limited1 Sanjun Cai1 Zou Junjie1 IBIOME BIOTECHNOLOGY CO., LTD1 ScinnoHub Pharmaceutical Co., Ltd.1 Shanghai Xinzhi BioMed Co., Ltd.1 Shanghai Lanyi Therapeutics Co., Ltd.1 Shenzhen Ionova Life Sciences Co., Ltd.1 Qurgen Inc.1 The First Affiliated Hospital of Zhengzhou University1 Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.1 YolTech Therapeutics Co., Ltd1 Wenjing Zhou1 Shanghai RAAS Blood Products Co., Ltd.1 Essilor International1 Hongxia Wang1 Dianthus Therapeutics1 Tyligand Pharmaceuticals (Suzhou) Limited1 Nanjing Zenshine Pharmaceuticals1 Xiangya Hospital of Central South University1 First Affiliated Hospital, Sun Yat-Sen University1 DiproBio (Shanghai) Co., Ltd.1 Idience Co., Ltd.1 Dongyi He1 Beijing Chao Yang Hospital1 Novo Nordisk A/S1 Guang Ning1 Yifeng Jing1 Hunan Kelun Pharmaceutical Co., Ltd.1 Suzhou Hearthill Medical Technology Co.,LTD1 United Innomed(Shanghai) Limited1 Merz North America, Inc.1 Impact Therapeutics, Inc.1 Mu-qing Yang1 Sun Yat-Sen University Cancer Center1 Full-Life Technologies UK Limited1 Chongqing Jinsaixing Medical Technology Co., Ltd1 Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.1 First People's Hospital of Hangzhou1 Pyrotech Therapeutics, Inc.1 Genrix (Shanghai) Biopharmaceutical Co., Ltd.1 Xiaohua Wu1 Danyang Huichuang Medical Equipment Co., Ltd.1 Ye Xu1 Southeast University, China1 Avistone Pharmaceutical（Ningbo）Co., LTD.1 Sichuan Huiyu Pharmaceutical Co., Ltd1 NeuShen Therapeutics1 Chen Xiangmei1 Shanghai Ruiwei Digital Technology Co. Ltd.1 Long Jiang1 The Children's Hospital of Zhejiang University School of Medicine1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.1 Shanghai Teyi Yinuo Health Technology Co., Ltd.1 Shen yang1 Skyline Therapeutics1 Ying HUANG1 MedtronicNeuro1 Zhongshan Ophthalmic Center, Sun Yat-sen University1 Acerand Therapeutics (Hong Kong) Limited1 Jialei Wang1 Singlomics Biopharmaceuticals Zhuhai Co., Ltd.1 Yicheng Ma1 Ranok Therapuetics Co. Ltd.1 Beijing StoneWise Technology Co., Ltd1 Vividion Therapeutics, Inc.1 Bordeaux Colorectal Institute1 First Affiliated Hospital of Fujian Medical University1 Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.1 Hangzhou Sciwind Biosciences Co., Ltd.1 Hangzhou DAC Biotechnology Co., Ltd.1 Yung NA1 Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.1 Shanghai Kechow Pharma, Inc.1 Xinghua Cheng1 Primelink BioTherapeitics(ShenZhen) Limited1 Yibin Fang1 Shanghai Huihe Medical Technology Co., Ltd1 Guangzhou Excelmab Inc.1 Shanghai Cingularbio Co. Ltd1 Limin Zhang1 Jilin University1 European Myeloma Network B.V.1 The Cleveland Clinic1 Shanghai Siponuoyin Biotechnology Co Ltd1 Shanghai Shengdi Pharmaceutical Co., Ltd1 Chang Chen1 Nutshell Therapeutics (Shanghai) Co., LTD.1 Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.1 Ruitherapeutics Co., LTD1 Loxo Oncology, Inc.1 Johnson & Johnson Medical (Shanghai) Ltd.1 Astellas (Beijing) Pharmaceutical R&D Co., Ltd.1 Telix Pharmaceuticals (Innovations) Pty Limited1 Shanghai Punan Hospital of Pudong New District1 Cutia Therapeutics（Wuxi）Co.,Ltd1 Neukio Biotherapeutics (Shanghai) Co., Ltd.1 Liu Cheng1 Wei Xu1 Genecombio Ltd.1 Novlead Inc.1 VivaVision Biotech, Inc1 Peijia Medical Technology (Suzhou) Co., Ltd.1 Everest Medicines (Beijing) Co., Ltd.1 Mingge LLC1 Xuebo Liu1 QuantX Biosciences US Inc.1 Tasly Biopharmaceuticals Co., Ltd.1 Ding-Wei Ye1 Kousai Bio Co., Ltd.1 China Immunotech (Beijing) Biotechnology Co., Ltd.1 EnnovaBio1 The Affiliated Hospital of Xuzhou Medical University1 Xia Peng1 Bangdong Gong1 Lei-Miao Yin1 Beijing 302 Hospital1 Shanghai Hansoh Biomedical Co., Ltd1 Wei Gong1 Shanghai Ruiliyuan Biotechnology Co., Ltd.1 TransThera Sciences (Nanjing), Inc.1 Jinsong Lu1 Suzhou Junde Biotechnology Co., Ltd1 Hebei Senlang Biotechnology Inc., Ltd.1 VeonGen Therapeutics GmbH1 Belief BioMed (Beijing) Co., Ltd1 CorrectSequence Therapeutics Co., Ltd1 Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.1 ShanShan Li1 Yanbing Li1 Ractigen Therapeutics.1 Albireo, an Ipsen Company1 Galderma R&D1 Shaanxi Micot Pharmaceutical Technology Co., Ltd.1 Feng Tao1 L'Oreal1 Xian-Jun Yu1 Shanghai Hutchison Pharmaceuticals Limited1 kewen Chen,MD1 Xi Tan1 Ding Ke-Feng1 Jecho Biopharmaceuticals Co., Ltd.1 Daiichi Sankyo Co., Ltd.1 United Therapeutics1 Sunnybrook Health Sciences Centre1 Xizang Haisco Pharmaceutical Co., Ltd1 Lunan Better Pharmaceutical Co., LTD.1 WestVac Biopharma Co., Ltd.1 Sir Run Run Shaw Hospital1 Xi Junjie1 Medtronic Vascular1 West China Hospital1 King's College London1 HOYA Lens Thailand LTD.1 Beijing DCTY Biotech Co.,Ltd.1 Biocity Biopharmaceutics Co., Ltd.1 Shanghai Yizhong Pharmaceutical Co., Ltd.1 FindCure Biosciences (ZhongShan) Co., Ltd.1 Beijing University of Chinese Medicine1 Taiho Pharmaceutical Co., Ltd.1 Lanyue Biotech (Hangzhou) Co., Ltd.1 DeltaHealth Hospital · Shanghai1 Yanbing Yu1 Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine1 XiaoJing Zou,MD1 Probi AB1 Shanghai Jiatan Pharmatech Co., Ltd1 Synusight Biotech (Shanghai) Co., Ltd.1 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.1 Children's Hospital of Philadelphia1 Biotech Pharmaceutical Co., Ltd.1 Ya-Wei Xu1 GV20 Therapeutics1 Biotyx Medical (Shenzhen) Co., Ltd.1 Wenxian Li1 Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 Wuxi Cellular Biopharmaceutical Group Ltd.1 Hangzhou Huasai Biomedicine Co., Ltd.1 Shanghai TTM-Bio Technology Co., Ltd1 Jiangsu Healthy Life Innovation Medical Technology Co., Ltd1 Jian Pei,MD1 Shanghai Pudong New Area Gongli Hospital1 Ascentawits Pharmaceuticals, Ltd1 Jemincare1 Qiyu Bo1 TaiRx, Inc.1 Beth Israel Deaconess Medical Center1 Tarapeutics Science Inc.1 Jie Liang1 Hefei TG ImmunoPharma Co., Ltd.1 JHM BioPharma (Tonghua) Co. , Ltd.1 Regeneron Pharmaceuticals1 Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.1 Chongbo Zhao1 Suzhou Junjing BioSciences Co., Ltd.1 HitGen Inc.1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Zhimin Shao1 Second People's Hospital, Shanghai1 Shanghai MicroPort EP MedTech Co., Ltd.1 Beyang Therapeutics Co., Ltd.1 Suzhou Mednovo Yi Medical Technology Co., Ltd.1 SyMap Medical (Suzhou), Ltd.1 ShanghaiTech University1 ChromX Health1 Innatus Therapeutics (Shanghai) Co., Ltd.1 Jun Zhang1 Junyu Shi1 Jiangsu Aidea Pharmaceutical Group Co., Ltd.1 Istituto Auxologico Italiano1 Vantive Health LLC1 Guangzhou Gloria Biosciences Co., Ltd.1 Multitude Therapeutics Inc.1 I-Mab Biopharma US Limited1 Qiang Dong1 Hongmei Wang1 Colorado Prevention Center1 ChunBao Li1 CLASSYS Inc.1 Zhuhai United Laboratories Co., Ltd.1 Guo ShiWei1 Shanghai Yuyao Biotech Co., Ltd.1 Shanghai Jeyou Pharmaceutical Co., Ltd.1 Chinese Academy of Medical Sciences, Fuwai Hospital1 xieqing1 Putuo Hospital, Shanghai University of Traditional Chinese Medicine1 Elpiscience (Suzhou) Biopharma, Ltd.1 Zhang Manna1 Qingyou Meng1 Kanglin Biotechnology (Hangzhou) Co., Ltd.1 NextCure, Inc.1 Tong Chen, MD1 Usynova Pharmaceuticals Ltd.1 Beijing Tongren Hospital1 Institute of Hematology & Blood Diseases Hospital, China1 Guangzhou Sinogen Pharmaceutical Co., Ltd1 Beijing Sungen Biomedical Technology Co., Ltd1 Neuracle Medical Technology(Shanghai) Co.,Ltd.1 Servier1 Shanghai Golden Leaf MedTec Co. Ltd1 Brigham and Women's Hospital1 ZHOU FANGJIAN1 Xian-Janssen Pharmaceutical Ltd.1 Sinotau Pharmaceutical Group1 Hangzhou Adcoris Biopharmacy Co., Ltd1 Zhaoyun Zhang1 Kuang XiaoJun1 Jun Zhou1 Jian Zhuo1 Aragon Pharmaceuticals, Inc.1 LeMaitre Vascular1 JYAMS PET Research & Development Limited1 Adicet Therapeutics1 Rongchang Pharmaceuticals Co., Ltd.1 Seung-Jung Park1 Epigenic Therapeutics, Inc1 Suzhou Hengruihongyuan Medical Technology Co. LTD1 Chen QiYi1 TJ Biopharma Co., Ltd.1 Guangzhou Lupeng Pharmaceutical Company LTD.1 Kai Wang1 Xu jianmin1 Medtecx Co Ltd.1 Antengene Biologics Limited1 CoreAalst BV1 Cytori Therapeutics1 Mitrassist Lifesciences Limited Co., Ltd.1 Fujian Medical University Union Hospital1 ITM Solucin GmbH1 Huazhong University of Science and Technology1 PharmaEssentia1 Liangjing Lu1 Shanghai Novamab Biopharmaceuticals Co., Ltd.1 Shanghai Guangsheng Biopharmaceutical Co., Ltd1 Jin Xu1 M.D. Anderson Cancer Center1 Vigonvita Life Sciences1 Taiho Oncology, Inc.1 Women's Hospital School Of Medicine Zhejiang University1 CStone Pharmaceuticals1 Vivacta Biotechnology (Shanghai) Co., Ltd.1 Guangzhou JOYO Pharma Co., Ltd1 Lee's Pharmaceutical Limited1 Nerviano Medical Sciences (Shanghai) Ltd.1 Allist Pharmaceuticals, Inc.1 Shanghai HyaMab Biotech Co.,Ltd.1 Jia Xiu1 Neuregen Therapeutics Co., Ltd.1 Minghui Pharmaceutical (Shanghai) LTD1 Sinocelltech Ltd.1 Guangzhou University of Traditional Chinese Medicine1 R1 Therapeutics1 Chengdu Suncadia Medicine Co., Ltd.1 Shanghai Huicun Medical Technology Co., Ltd.1 Kind Pharmaceuticals LLC1 HighField Biopharmaceuticals Corporation1 Shanghai Chest Hospital of Shanghai Jiao Tong University1 Junbo Ge1 Beijing Boren Hospital1 Stanford University1 SUNHO（China）BioPharmaceutical CO., Ltd.1 Hefei Xinzhu Biological Technology Co., Ltd.1 Chengdu JOYO pharma Co., Ltd.1 The United Bio-Technology (Hengqin) Co., Ltd.1 Regor Pharmaceuticals Inc.1 Suzhou Sanegene Bio Inc.1 B. Braun Medical International Trading Company Ltd.1 NS Pharma, Inc.1 Mabsoft Therapeutics (Shanghai) Co., Ltd.1 Hangzhou Converd Co., Ltd.1 Min Hou1 Zhang Jianguo1 Huan Zhou1 HALEON1 Renmin Hospital of Wuhan University1 Hecheng Li M.D., Ph.D1 Shen Feng1 LinGang Laboratory1 Yu Wang1 VitsGen Therapeutics Inc.1 TCRx Therapeutics Co.Ltd1 Jiangxi Kvvit Pharmaceutical Co., Ltd.1 Da Fu1 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd1 Sun Yuting1 Beijing Daxiang Biotech Co., Ltd1 SmartNuclide Biopharma1 Medolution Ltd.1 XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.1 The First Affiliated Hospital of Soochow University1 C Ray Therapeutics1 Brii Biosciences Limited1 Pengpeng Xu1 Beijing Biostar Pharmaceuticals Co., Ltd.1 Jian Li1 Kunwei Shen1 Lu jin ，MD1 Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1 Henan Institute of Cardiovascular Epidemiology1 Tianjin Puli Ark Medical Technology Co., Ltd.1 First Affiliated Hospital Xi'an Jiaotong University1 GeneSail Biotech (Shanghai) Co., Ltd.1 Jiang Long1 Clear sponsor filter
Site location
Beijing64 Guangzhou47 Chengdu45 Changsha37 Chongqing29 Shanghai25 Hefei25 Changchun25 Hangzhou24 Jinan24 Harbin21 Luoyang Shi14 Changzhou12 Tianjin12 Fuzhou10 Changde10 Nanjing10 Wuhan8 Nanchang8 Haikou6 Huzhou6 Foshan5 Luoyang5 Bengbu5 Suzhou5 Xiamen4 Wuhu4 Shenzhen4 Wenzhou4 Huizhou4 Lanzhou3 Anyang3 Minhang District3 Nanning3 Ningbo3 Zhengzhou3 Guangdong3 Xi'an3 Baotou3 Lishui3 Shijiazhuang3 Binzhou3 Guiyang2 Deyang2 Fuzhou Fujian2 Jiangmen2 Chaohu2 Haidian District2 Cheng Du Shi2 Hengyang2 Meihekou2 Kunming2 Chifeng1 Tainan1 Taipei1 Taoyuan1 Dalian1 Zhanjiang1 Zhongshan1 Jingzhou1 Linhai1 Taizhou1 Jiangyin1 Pingxiang1 Baoding1 Linfen1 Daqing1 Liaoyou1 Qingdao1 Shenyang1 Zhumadian1 Qinhuangdao Shi1 Changping1 Hengshui Shi1 Xuzhou1
All 75 locations
Target enrolment
to

Trials with a site in Shanghai

25 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
NCT07843459Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
Eli Lilly and Company
Phase 1
111
Beijing, Minhang District, Shanghai
2026-10
Recruiting
Eli Lilly and Company
Phase 1
179
Beijing, Minhang District, Shanghai
2026-09-09
Recruiting
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08-14
Recruiting
Eli Lilly and Company
Phase 2
606
Baotou, Beijing, Chengdu, Guangzhou, Jiangyin, Jinan, Pingxiang, Shanghai
2026-08-07
Recruiting
Eli Lilly and Company
Phase 2
65
Beijing, Shanghai, Tianjin
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
DrugLY4005130
Eli Lilly and Company
Phase 2
66
Beijing, Hangzhou, Shanghai, Shenzhen
2026-04-14
Recruiting
Eli Lilly and Company
Phase 4
150
Beijing, Changsha, Guangdong, Guangzhou, Lanzhou, Nanchang, Shanghai, Taizhou
2026-03-09
Recruiting
Eli Lilly and Company
Phase 1
68
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
2026-02-04
Recruiting
Eli Lilly and Company
Phase 2
60
Beijing, Chengdu, Guangzhou, Luoyang, Shanghai, Xuzhou
2025-12-08
Recruiting
Eli Lilly and Company
Phase 2
400
Changsha, Hangzhou, Huzhou, Jinan, Shanghai, Shijiazhuang, Tianjin, Xiamen
2025-11-24
Recruiting
Eli Lilly and Company
Phase 3
1,205
Beijing, Chengdu, Guangzhou, Harbin, Luoyang Shi, Nanjing, Shanghai, Tianjin
2025-10-31
Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT07213791Ovarian Neoplasms, Breast Neoplasms, Pancreatic Intraductal Neoplasms, Colorectal Neoplasms
Eli Lilly and Company
Phase 1
340
Shanghai
2025-10-22
Recruiting
Eli Lilly and Company
Phase 2
531
Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai
2025-10-22
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
NCT07787182Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
DrugLY4405094
Eli Lilly and Company
Phase 1
68
Beijing, Minhang District, Shanghai
2025-10-14
Active, closed
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
NCT07162181Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, B-cell Lymphoma
DrugPirtobrutinib
Eli Lilly and Company
Phase 2
13
Beijing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan
2025-08-07
Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms, Neoplasm Metastasis
DrugsCisplatin·Carboplatin·Pembrolizumab
Eli Lilly and Company
Phase 1
240
Chengdu, Shanghai, Wuhan
2025-07-28
Active, closed
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06586515Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
DrugsLeucovorin·Irinotecan·Cetuximab·Adrucil
Eli Lilly and Company
Phase 1
630
Beijing, Harbin, Shanghai
2024-09-12
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT06465069Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
DrugPembrolizumab
Eli Lilly and Company
Phase 1
460
Beijing, Guangzhou, Shanghai
2024-07-01
Active, closed
Eli Lilly and Company
Phase 3
450
Beijing, Changsha, Guangzhou, Hangzhou, Jingzhou, Nanchang, Nanning, Shanghai
2024-04-26
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Beijing, Changsha, Shanghai
2024-03-05
Recruiting
Eli Lilly and Company
Phase 1
677
Beijing, Guangdong, Hangzhou, Shanghai, Tianjin, Xi'an
2023-01-12
Active, closed
Eli Lilly and Company
Phase 1
17
Wuhu, Changsha, Nanchang, Shanghai
2022-10-09
Active, closed
Eli Lilly and Company
Phase 1
260
Beijing, Nanchang, Shanghai
2022-05-11
Active, closed
Eli Lilly and Company
Phase 2
77
Beijing, Guangzhou, Changsha, Changchun, Jinan, Shanghai, Tianjin, Hangzhou
2020-03-16
Active, closed
Eli Lilly and Company
Phase 3
261
Beijing, Guangzhou, Harbin, Wuhan, Changsha, Changzhou, Changchun, Shanghai
2020-02-17
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Shanghai that also match the filters currently applied.

How many clinical trials are recruiting in Shanghai?

16 of the 25 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shanghai), 25 studies
PhaseStudiesRecruitingShare
Phase 112748%
Phase 28632%
Phase 34216%
Phase 4114%

Most active sponsors

Lead sponsors with the most studies (Shanghai)
Lead sponsorStudiesRecruiting
Eli Lilly and Company2516
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.